Policy Updates Blogs

03|13|26

FDA Warning & Untitled Letters: What Pharma Marketers Need To Know 

The FDA’s recent untitled letters signal heightened scrutiny of promotional practices. Download the POV to learn what pharma marketers need to know, and how to proactively mitigate risk while staying compliant.